According to the latest report by IMARC Group, titled “Carrier Screening Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” The global carrier screening market size reached US$ 1.5 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 2.9 Billion by 2027, exhibiting a growth rate (CAGR) of 11.4% during 2022-2027. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the market in any form.
Market Global Outlook:
Carrier screening is a category of genetic test that is used to determine if a person is a carrier of genetic or specific autosomal recessive diseases. It is a pre-symptomatic and predictive testing solution that provides life-lasting information about the reproductive risks of an individual and their chances of having a child with genetic disorders. The screening involves the testing of the samples of saliva, cheek tissue, or blood to detect the presence of an abnormal gene for disorders such as sickle cell anemia, cystic fibrosis, and Tay-Sachs disease. These samples are then screened using molecular and biochemical processes based on polymerase chain reaction (PCR), deoxyribonucleic acid (DNA) sequencing, and microarray technologies.
Download to Get the Free Sample Report: https://www.imarcgroup.com/carrier-screening-market/requestsample
Market Trends and Drivers:
The growing consumer awareness regarding early disease detection and prevention and the inflating consumer per capita income are some of the factors providing an impetus to the market growth. Apart from this, the rising awareness regarding carrier screening and the burgeoning prevalence of fetal chromosomal abnormalities and genetic disorders are bolstering the market growth. Furthermore, the emergence of advanced diagnostic tests and increasing research and development (RD) activities in biotechnology and bioinformatics are accelerating the market growth. Moreover, the development of next-generation sequencing (NGS) techniques by key players and rising investments in clinical trials are creating a positive outlook for the market.
Carrier Screening Market 2022-2027 Competitive Analysis and Segmentation:
The competitive landscape of the global carrier screening market has been studied in the report with the detailed profiles of the key players operating in the market.
Key Players in Carrier Screening Market Report:
- Fulgent Genetics (NASDAQ: FLGT)
- Gene By Gene Ltd. (MyDNA) (OTCMKTS: GNTLF)
- Illumina Inc. (NASDAQ: ILMN)
- Invitae Corporation (NYSE: NVTA)
- MedGenome Labs Ltd.
- Myriad Genetics Inc. (NASDAQ: MYGN)
- Natera Inc. (NASDAQ: NTRA)
- OPKO Health Inc. (NASDAQ: OPK)
- Quest Diagnostics (NYSE: DGX)
- Sema4 (NASDAQ: SMFR)
- Thermo Fisher Scientific Inc. (NYSE: TMO)
Buy Report: https://www.imarcgroup.com/checkout?id=4417method=1
Market Segmentation:
The report has segmented the global carrier screening market on the basis of type, medical condition, technology, end user and region.
Breakup by Type:
- Expanded Carrier Screening
- Targeted Disease Carrier Screening
Breakup by Medical Condition:
- Pulmonary Conditions
- Hematological Conditions
- Neurological Conditions
- Others
Breakup by Technology:
- DNA Sequencing
- Polymerase Chain Reaction
- Microarrays
- Others
Breakup by End User:
- Hospitals and Clinics
- Reference Laboratories
- Others
Geographical Analysis:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
Key Highlights of the Report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: https://www.imarcgroup.com/
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe Africa: +44-753-713-2163 | Asia: +91-120-433-0800
